Umair Aziz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Umair Aziz has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Ghulam Farid
Institute of Information Management, University of the Punjab, Lahore, Pakistan
3 shared publications - Muhammad Zahid Bashir
Shalamar Medical and Dental College, Lahore, Pakistan
3 shared publications - Anila Jaleel
Shalamar Medical and Dental College, Lahore, Pakistan
2 shared publications - Rana Muhammad Hassaan Sikander
Shalamar Medical and Dental College, Lahore, Pakistan
2 shared publications - Shiraz Aslam
Shalamar Medical and Dental College, Lahore, Pakistan
2 shared publications - Syed Mohammad Khizar Abbas
Shalamar Medical and Dental College, Lahore, Pakistan
2 shared publications
Latest Publications
- Open Access
Telomere Length as an Indicator of Lifestyle-Related Biological Aging in Hypertensive Adults: A Pilot Exploratory Study
Background: Multiple epidemiological studies have given a global perspective that hypertension leads to changes in telomere length (TL). This study aimed to investigate the association between leukocyte telomere length and lifestyle factors among individuals with hypertension, a family history of the disease and healthy controls. Methods: This pilot exploratory cross-sectional study included 45 participants (n = 15 per group) divided into hypertensive, familial hypertensive, and control groups. Lifestyle behaviors were assessed using the FANTASTIC Lifestyle Checklist, evaluating domains such as physical activity, diet, sleep, and stress. Relative telomere length (T/S ratio) of leucocytes was measured from peripheral blood samples using quantitative real-time PCR (qPCR). Data were analyzed using SPSS software, with ANOVA, Kruskal-Wallis test, and multivariable linear regression applied for statistical analysis. Results: Relative telomere length differed significantly among the study groups (p = 0.008), with hypertensive participants demonstrating the highest median telomere-to-single-copy gene (T/S) ratio (2.66), followed by familial hypertensive (1.25) and control participants (0.87). Total lifestyle scores also varied significantly across groups (p < 0.001), with hypertensive individuals exhibiting higher mean scores (77.07 ± 5.59) than familial hypertensive (67.20 ± 3.00) and control participants (67.07 ± 5.97). A modest positive correlation was observed between total lifestyle score and relative telomere length (r = 0.329, p < 0.05), suggesting that healthier lifestyle behaviors in diagnosed hypertensive subjects following healthy lifestyles and regular medications were associated with longer telomeres. However, in multivariable linear regression analyses, lifestyle score, age, gender, hypertension status, and family history of hypertension were not independently associated with telomere length (all p > 0.05). Conclusion: Lifestyle scores were positively associated with telomeres, and significantly higher telomere ratios in hypertensive subjects suggest complex biological interactions that require further investigation through larger longitudinal studies in the target population.
Open AccessTelomere Length as an Indicator of Lifestyle-Related Biological Aging in Hypertensive Adults: A Pilot Exploratory Study
Background: Multiple epidemiological studies have given a global perspective that hypertension leads to changes in telomere length (TL). This study aimed to investigate the association between leukocyte telomere length and lifestyle factors among individuals with hypertension, a family history of the disease and healthy controls. Methods: This pilot exploratory cross-sectional study included 45 participants (n = 15 per group) divided into hypertensive, familial hypertensive, and control groups. Lifestyle behaviors were assessed using the FANTASTIC Lifestyle Checklist, evaluating domains such as physical activity, diet, sleep, and stress. Relative telomere length (T/S ratio) of leucocytes was measured from peripheral blood samples using quantitative real-time PCR (qPCR). Data were analyzed using SPSS software, with ANOVA, Kruskal-Wallis test, and multivariable linear regression applied for statistical analysis. Results: Relative telomere length differed significantly among the study groups (p = 0.008), with hypertensive participants demonstrating the highest median telomere-to-single-copy gene (T/S) ratio (2.66), followed by familial hypertensive (1.25) and control participants (0.87). Total lifestyle scores also varied significantly across groups (p < 0.001), with hypertensive individuals exhibiting higher mean scores (77.07 ± 5.59) than familial hypertensive (67.20 ± 3.00) and control participants (67.07 ± 5.97). A modest positive correlation was observed between total lifestyle score and relative telomere length (r = 0.329, p < 0.05), suggesting that healthier lifestyle behaviors in diagnosed hypertensive subjects following healthy lifestyles and regular medications were associated with longer telomeres. However, in multivariable linear regression analyses, lifestyle score, age, gender, hypertension status, and family history of hypertension were not independently associated with telomere length (all p > 0.05). Conclusion: Lifestyle scores were positively associated with telomeres, and significantly higher telomere ratios in hypertensive subjects suggest complex biological interactions that require further investigation through larger longitudinal studies in the target population.
- Top Cited PapersOpen Access
- 19 September 2025
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 11 (1) , e68070
Evaluating the Potential and Accuracy of ChatGPT-3.5 and 4.0 in Medical Licensing and In-Training Examinations: Systematic Review and Meta-Analysis
Background: Artificial intelligence (AI) has significantly impacted health care, medicine, and radiology, offering personalized treatment plans, simplified workflows, and informed clinical decisions. ChatGPT (OpenAI), a conversational AI model, has revolutionized health care and medical education by simulating clinical scenarios and improving communication skills. However, inconsistent performance across medical licensing examinations and variability between countries and specialties highlight the need for further research on contextual factors influencing AI accuracy and exploring its potential to enhance technical proficiency and soft skills, making AI a reliable tool in patient care and medical education. Objective: This systematic review aims to evaluate and compare the accuracy and potential of ChatGPT-3.5 and 4.0 in medical licensing and in-training residency examinations across various countries and specialties. Methods: A systematic review and meta-analysis were conducted, adhering to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Data were collected from multiple reputable databases (Scopus, PubMed, JMIR Publications, Elsevier, BMJ, and Wiley Online Library), focusing on studies published from January 2023 to July 2024. Analysis specifically targeted research assessing ChatGPT’s efficacy in medical licensing exams, excluding studies not related to this focus or published in languages other than English. Ultimately, 53 studies were included, providing a robust dataset for comparing the accuracy rates of ChatGPT-3.5 and 4.0. Results: ChatGPT-4 outperformed ChatGPT-3.5 in medical licensing exams, achieving a pooled accuracy of 81.8%, compared to ChatGPT-3.5’s 60.8%. In in-training residency exams, ChatGPT-4 achieved an accuracy rate of 72.2%, compared to 57.7% for ChatGPT-3.5. The forest plot presented a risk ratio of 1.36 (95% CI 1.30-1.43), demonstrating that ChatGPT-4 was 36% more likely to provide correct answers than ChatGPT-3.5 across both medical licensing and residency exams. These results indicate that ChatGPT-4 significantly outperforms ChatGPT-3.5, but the performance advantage varies depending on the exam type. This highlights the importance of targeted improvements and further research to optimize ChatGPT-4’s performance in specific educational and clinical settings. Conclusions: ChatGPT-4.0 and 3.5 show promising results in enhancing medical education and supporting clinical decision-making, but they cannot replace the comprehensive skill set required for effective medical practice. Future research should focus on improving AI’s capabilities in interpreting complex clinical data and enhancing its reliability as an educational resource.
- 19 September 2025
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 11 (1) , e68070
Top Cited PapersOpen AccessEvaluating the Potential and Accuracy of ChatGPT-3.5 and 4.0 in Medical Licensing and In-Training Examinations: Systematic Review and Meta-Analysis
Background: Artificial intelligence (AI) has significantly impacted health care, medicine, and radiology, offering personalized treatment plans, simplified workflows, and informed clinical decisions. ChatGPT (OpenAI), a conversational AI model, has revolutionized health care and medical education by simulating clinical scenarios and improving communication skills. However, inconsistent performance across medical licensing examinations and variability between countries and specialties highlight the need for further research on contextual factors influencing AI accuracy and exploring its potential to enhance technical proficiency and soft skills, making AI a reliable tool in patient care and medical education. Objective: This systematic review aims to evaluate and compare the accuracy and potential of ChatGPT-3.5 and 4.0 in medical licensing and in-training residency examinations across various countries and specialties. Methods: A systematic review and meta-analysis were conducted, adhering to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Data were collected from multiple reputable databases (Scopus, PubMed, JMIR Publications, Elsevier, BMJ, and Wiley Online Library), focusing on studies published from January 2023 to July 2024. Analysis specifically targeted research assessing ChatGPT’s efficacy in medical licensing exams, excluding studies not related to this focus or published in languages other than English. Ultimately, 53 studies were included, providing a robust dataset for comparing the accuracy rates of ChatGPT-3.5 and 4.0. Results: ChatGPT-4 outperformed ChatGPT-3.5 in medical licensing exams, achieving a pooled accuracy of 81.8%, compared to ChatGPT-3.5’s 60.8%. In in-training residency exams, ChatGPT-4 achieved an accuracy rate of 72.2%, compared to 57.7% for ChatGPT-3.5. The forest plot presented a risk ratio of 1.36 (95% CI 1.30-1.43), demonstrating that ChatGPT-4 was 36% more likely to provide correct answers than ChatGPT-3.5 across both medical licensing and residency exams. These results indicate that ChatGPT-4 significantly outperforms ChatGPT-3.5, but the performance advantage varies depending on the exam type. This highlights the importance of targeted improvements and further research to optimize ChatGPT-4’s performance in specific educational and clinical settings. Conclusions: ChatGPT-4.0 and 3.5 show promising results in enhancing medical education and supporting clinical decision-making, but they cannot replace the comprehensive skill set required for effective medical practice. Future research should focus on improving AI’s capabilities in interpreting complex clinical data and enhancing its reliability as an educational resource.
- Open Access
- 21 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Exploring the Use of Metaverse in Future Medical Education: Navigating Adoption and Challenges (Preprint)
BACKGROUND The metaverse driven by immersive technologies such as virtual reality (VR), augmented reality (AR), mixed reality (MR), artificial intelligence (AI), and blockchain has begun to reshape medical education. By creating highly interactive and personalized learning environments, the metaverse offers promising opportunities to enhance experiential learning, foster collaboration, and overcome geographic and resource barriers. OBJECTIVE This systematic review aimed to assess the current adoption and challenges of metaverse technologies in medical education. METHODS Following PRISMA guidelines, six major databases were searched in November 2024 and updated in June 2025. Eligible studies were English-language publications from 2021 to 2025 investigating metaverse applications in medical and clinical education. Exclusion criteria were non-English studies, articles under two pages, book chapters and studies unrelated to medical education. After screening and quality assessment, 41 studies were included for qualitative synthesis. RESULTS Evidence shows that the metaverse enhances experiential learning via simulated clinical environments, remote virtual dissections, AI-driven diagnostics, and collaborative global training. It expands accessibility, particularly for learners in underserved areas, by reducing geographic and financial barriers. However, significant challenges remain: high costs, limited infrastructure, privacy and data security concerns, digital literacy gaps, and resistance to adoption; especially in low and middle-income countries. Despite its promise, the metaverse cannot fully replace traditional hands-on clinical practice. Its successful integration into curricula depends on rigorous, evidence-based strategies and supportive policy frameworks. CONCLUSIONS The adoption of metaverse technologies represents a transformative shift in medical education. These simulations may enrich clinical skill training, encourage global collaboration, and support learner autonomy, mental well-being, and lifelong learning; particularly for students in remote or underserved areas. However, substantial challenges must be addressed, including privacy concerns, financial constraints, technological disparities, and ethical considerations. Realizing this potential requires evidence-based integration, ethical safeguards, inclusive strategies, and supportive policies that preserve the humanistic core of healthcare. CLINICALTRIAL N/A
- 21 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessExploring the Use of Metaverse in Future Medical Education: Navigating Adoption and Challenges (Preprint)
BACKGROUND The metaverse driven by immersive technologies such as virtual reality (VR), augmented reality (AR), mixed reality (MR), artificial intelligence (AI), and blockchain has begun to reshape medical education. By creating highly interactive and personalized learning environments, the metaverse offers promising opportunities to enhance experiential learning, foster collaboration, and overcome geographic and resource barriers. OBJECTIVE This systematic review aimed to assess the current adoption and challenges of metaverse technologies in medical education. METHODS Following PRISMA guidelines, six major databases were searched in November 2024 and updated in June 2025. Eligible studies were English-language publications from 2021 to 2025 investigating metaverse applications in medical and clinical education. Exclusion criteria were non-English studies, articles under two pages, book chapters and studies unrelated to medical education. After screening and quality assessment, 41 studies were included for qualitative synthesis. RESULTS Evidence shows that the metaverse enhances experiential learning via simulated clinical environments, remote virtual dissections, AI-driven diagnostics, and collaborative global training. It expands accessibility, particularly for learners in underserved areas, by reducing geographic and financial barriers. However, significant challenges remain: high costs, limited infrastructure, privacy and data security concerns, digital literacy gaps, and resistance to adoption; especially in low and middle-income countries. Despite its promise, the metaverse cannot fully replace traditional hands-on clinical practice. Its successful integration into curricula depends on rigorous, evidence-based strategies and supportive policy frameworks. CONCLUSIONS The adoption of metaverse technologies represents a transformative shift in medical education. These simulations may enrich clinical skill training, encourage global collaboration, and support learner autonomy, mental well-being, and lifelong learning; particularly for students in remote or underserved areas. However, substantial challenges must be addressed, including privacy concerns, financial constraints, technological disparities, and ethical considerations. Realizing this potential requires evidence-based integration, ethical safeguards, inclusive strategies, and supportive policies that preserve the humanistic core of healthcare. CLINICALTRIAL N/A
- Open Access
- 28 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Evaluating the Potential and Accuracy of ChatGPT-3.5 and 4.0 in Medical Licensing and In-Training Examinations: Systematic Review and Meta-Analysis (Preprint)
BACKGROUND Artificial intelligence (AI) has significantly impacted health care, medicine, and radiology, offering personalized treatment plans, simplified workflows, and informed clinical decisions. ChatGPT (OpenAI), a conversational AI model, has revolutionized health care and medical education by simulating clinical scenarios and improving communication skills. However, inconsistent performance across medical licensing examinations and variability between countries and specialties highlight the need for further research on contextual factors influencing AI accuracy and exploring its potential to enhance technical proficiency and soft skills, making AI a reliable tool in patient care and medical education. OBJECTIVE This systematic review aims to evaluate and compare the accuracy and potential of ChatGPT-3.5 and 4.0 in medical licensing and in-training residency examinations across various countries and specialties. METHODS A systematic review and meta-analysis were conducted, adhering to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Data were collected from multiple reputable databases (Scopus, PubMed, JMIR Publications, Elsevier, BMJ, and Wiley Online Library), focusing on studies published from January 2023 to July 2024. Analysis specifically targeted research assessing ChatGPT’s efficacy in medical licensing exams, excluding studies not related to this focus or published in languages other than English. Ultimately, 53 studies were included, providing a robust dataset for comparing the accuracy rates of ChatGPT-3.5 and 4.0. RESULTS ChatGPT-4 outperformed ChatGPT-3.5 in medical licensing exams, achieving a pooled accuracy of 81.8%, compared to ChatGPT-3.5’s 60.8%. In in-training residency exams, ChatGPT-4 achieved an accuracy rate of 72.2%, compared to 57.7% for ChatGPT-3.5. The forest plot presented a risk ratio of 1.36 (95% CI 1.30-1.43), demonstrating that ChatGPT-4 was 36% more likely to provide correct answers than ChatGPT-3.5 across both medical licensing and residency exams. These results indicate that ChatGPT-4 significantly outperforms ChatGPT-3.5, but the performance advantage varies depending on the exam type. This highlights the importance of targeted improvements and further research to optimize ChatGPT-4’s performance in specific educational and clinical settings. CONCLUSIONS ChatGPT-4.0 and 3.5 show promising results in enhancing medical education and supporting clinical decision-making, but they cannot replace the comprehensive skill set required for effective medical practice. Future research should focus on improving AI’s capabilities in interpreting complex clinical data and enhancing its reliability as an educational resource.
- 28 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEvaluating the Potential and Accuracy of ChatGPT-3.5 and 4.0 in Medical Licensing and In-Training Examinations: Systematic Review and Meta-Analysis (Preprint)
BACKGROUND Artificial intelligence (AI) has significantly impacted health care, medicine, and radiology, offering personalized treatment plans, simplified workflows, and informed clinical decisions. ChatGPT (OpenAI), a conversational AI model, has revolutionized health care and medical education by simulating clinical scenarios and improving communication skills. However, inconsistent performance across medical licensing examinations and variability between countries and specialties highlight the need for further research on contextual factors influencing AI accuracy and exploring its potential to enhance technical proficiency and soft skills, making AI a reliable tool in patient care and medical education. OBJECTIVE This systematic review aims to evaluate and compare the accuracy and potential of ChatGPT-3.5 and 4.0 in medical licensing and in-training residency examinations across various countries and specialties. METHODS A systematic review and meta-analysis were conducted, adhering to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Data were collected from multiple reputable databases (Scopus, PubMed, JMIR Publications, Elsevier, BMJ, and Wiley Online Library), focusing on studies published from January 2023 to July 2024. Analysis specifically targeted research assessing ChatGPT’s efficacy in medical licensing exams, excluding studies not related to this focus or published in languages other than English. Ultimately, 53 studies were included, providing a robust dataset for comparing the accuracy rates of ChatGPT-3.5 and 4.0. RESULTS ChatGPT-4 outperformed ChatGPT-3.5 in medical licensing exams, achieving a pooled accuracy of 81.8%, compared to ChatGPT-3.5’s 60.8%. In in-training residency exams, ChatGPT-4 achieved an accuracy rate of 72.2%, compared to 57.7% for ChatGPT-3.5. The forest plot presented a risk ratio of 1.36 (95% CI 1.30-1.43), demonstrating that ChatGPT-4 was 36% more likely to provide correct answers than ChatGPT-3.5 across both medical licensing and residency exams. These results indicate that ChatGPT-4 significantly outperforms ChatGPT-3.5, but the performance advantage varies depending on the exam type. This highlights the importance of targeted improvements and further research to optimize ChatGPT-4’s performance in specific educational and clinical settings. CONCLUSIONS ChatGPT-4.0 and 3.5 show promising results in enhancing medical education and supporting clinical decision-making, but they cannot replace the comprehensive skill set required for effective medical practice. Future research should focus on improving AI’s capabilities in interpreting complex clinical data and enhancing its reliability as an educational resource.